Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / C•••••• P••••••• L••

C•••••• P••••••• L••

Institutional venture firmTokyoc•••••••••.comSEC venture capital fund adviser

Transforming Life Sciences Innovation By Creating And Investing In Global Companies

venture manager, reported GAV $527M across 3 vehicles

Importance
27
moderate
Active deployment
25
moderate
Emerging
0
low
Completeness
69
high
Freshness
99
high
Research priority
11
low
Identity and regulatory footprint
Headquarters
Tokyo, Japanadviserinfo.sec.gov
Office address
AUSPICE OMOTESANDO 8-14, MINAMI-AOYAMA 3-CHOME MINATO-KU, Tokyo, 107-0062adviserinfo.sec.gov
Business phone
81-50-1744-2996adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Oct 11, 2024
Private funds reported
3 (3 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$527Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
business email
info@catalyspacific.comcatalyspacific.compublished by the subject
business phone
81-50-1744-2996adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
biotech
Stages
early
Geography
global, japan, united states
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
3 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
C•••••• P•••••• F••• I• L•Fund2023 adv first reportedActive deployment$200M
Oct 11, 2024
11$0Jun 29, 2022
C•••••• P•••••• P••••••• F••• L•Fund2023 adv first reportedActive deployment$14.1M
Oct 11, 2024
3unknownunknown
C•••••• P•••••• F•••• L•Fund2018 form d first saleHarvest$313M
Oct 11, 2024
12$89.0M
of $100M
Jan 29, 2020
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
14 current, 1 departed
1 departed (kept with end dates)
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
5 dated events
  1. Sep 16, 2026
    R••• D•••• (Advisor) no longer on the team page of C•••••• P••••••• L••
  2. Mar 31, 2023
    C•••••• P•••••• F••• I• L• first reported on Form ADV by C•••••• P••••••• L•• (Venture Capital Fund), GAV $114,763,728
  3. Mar 31, 2023
    C•••••• P•••••• P••••••• F••• L• first reported on Form ADV by C•••••• P••••••• L•• (Venture Capital Fund), GAV $15,236,089
  4. May 6, 2019
    C•••••• P••••••• L•• first filed Form ADV (ERA, venture capital fund adviser exemption)
  5. May 6, 2019
    C•••••• P•••••• F•••• L• first reported on Form ADV by C•••••• P••••••• L•• (Venture Capital Fund), GAV $80,808,081
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $527M across 3 vehicles
Evidence
35 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC exemption claimedventure_capital_fund_adviserOct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserOct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2019-05-06Oct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-10-11Oct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Oct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone81-50-1744-2996Oct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Contact page urlhttps://c•••••••••.com/
contact page linked from the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionTransforming Life Sciences Innovation By Creating And Investing In Global Companies
meta description
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionTransforming Life Sciences Innovation By Creating And Investing In Global Companies
meta description
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersTokyo, JapanOct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office addressAUSPICE OMOTESANDO 8-14, MINAMI-AOYAMA 3-CHOME MINATO-KU, Tokyo, 107-0062Oct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formLimited Liability CompanyOct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported3Oct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$527MOct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyglobal,japan,united states
geography words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated geographyglobal,japan,united states
geography words on the home page
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
sector words on the home page
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesearly
stage words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesearly
stage words on the home page
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://c•••••••••.com/
13 name/title pairs read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://c•••••••••.com/
10 name/title pairs read
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported3Oct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://c•••••••••.com/Oct 11, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleC•••••• P••••••
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleC•••••• P••••••
title tag
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)